Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.
about
Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy?Microvascular vasodilator properties of the angiotensin II type 2 receptor in a mouse model of type 1 diabetes.Inhibition of endothelin-1 receptors improves impaired nitric oxide synthase-dependent dilation of cerebral arterioles in type-1 diabetic ratsGenetic interference with peroxisome proliferator-activated receptor γ in smooth muscle enhances myogenic tone in the cerebrovasculature via A Rho kinase-dependent mechanism.Protecting against vascular disease in brainThe role of oxidative stress and NADPH oxidase in cerebrovascular disease.Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertensionMicrovascular Dysfunction and Cognitive Impairment.Cerebrovascular complications of diabetes: focus on stroke.Role of Nox isoforms in angiotensin II-induced oxidative stress and endothelial dysfunction in brainAdrenergic signaling and oxidative stress: a role for sirtuins?Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.Vessel Dilation Attenuates Endothelial Dysfunction Following Middle Cerebral Artery Occlusion in Hyperglycemic Rats.Oxidative stress in cerebral small vessel disease. Role of reactive species.Regulation of cerebral vascular function by sirtuin 1.Rho-kinase and the nitric oxide pathway modulate basilar arterial reactivity to acetylcholine and angiotensin II in streptozotocin-induced diabetic mice.
P2860
Q26751153-C373A23F-DD5F-4EF6-AAC6-B0D3BA8385A1Q30843430-145CCDF8-F188-49C1-B443-8C1D34AB2FEBQ34067524-80435BEC-87A5-4169-92CB-13C3E269F7F4Q34892807-C9730C8A-C5E4-4359-9D58-66C2360769EFQ34979773-8BC13ECF-AAA8-4665-B1CE-99B38F2C3B87Q35118380-18050A2C-91BE-4D3B-83B4-A6FA74278D9EQ36660171-A2026015-B54E-4CB3-B6F4-0538943F76AEQ36839870-E448937D-9B13-4D47-84D4-273C22C5BB40Q37089769-F97892FA-BBCA-4005-A0AA-1A867134FD87Q37175450-9141824C-85F6-4CC8-8295-F870C759FEFDQ37289500-C7EEA4AF-EBBC-4E71-B1AA-B945A86B38ABQ39116577-6D0845B5-6735-42E7-BA8C-AFE58702112DQ40026751-9338828E-73A5-4F92-A777-31A888D9CAEEQ46255913-C0701C3E-E08F-4D3E-991E-FAB90E5C862AQ48669695-EDA44D16-D963-481B-A7DE-BEA19F71858DQ54305936-FA441964-313E-45C2-81A8-C69EABC89628
P2860
Losartan improves impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in type 1 diabetic rats.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Losartan improves impaired nit ...... ioles in type 1 diabetic rats.
@en
Losartan improves impaired nit ...... ioles in type 1 diabetic rats.
@nl
type
label
Losartan improves impaired nit ...... ioles in type 1 diabetic rats.
@en
Losartan improves impaired nit ...... ioles in type 1 diabetic rats.
@nl
prefLabel
Losartan improves impaired nit ...... ioles in type 1 diabetic rats.
@en
Losartan improves impaired nit ...... ioles in type 1 diabetic rats.
@nl
P2093
P2860
P1433
P1476
Losartan improves impaired nit ...... ioles in type 1 diabetic rats.
@en
P2093
Denise M Arrick
Glenda M Sharpe
William G Mayhan
P2860
P304
P356
10.1016/J.BRAINRES.2008.03.020
P407
P577
2008-03-21T00:00:00Z